Sarcoma — Trials · CancerIndex

Clinical trials

Registered studies

2,687 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 634
Recruiting: 364
Ph III recruiting: 20
Growth YoY: −14.6%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (365)

clinicaltrialsPublishedShowing 501–503 of 503 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00002314	A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma	completed	Phase 2	—	Hoffmann-La RocheINDUSTRY	1	Jun 24, 2005	clinicaltrials
NCT00005931	SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment	completed	Phase 2	30	SUGENINDUSTRY	1	Jun 24, 2005	clinicaltrials
NCT00041808